6/9/25 We are currently making changes to reflect the new Health Sciences Division structure. Thank you for your patience while we make the transition.

Sign in
Back
Response to Letter to the Editor Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression
Letter/Communication   Peer reviewed

Response to Letter to the Editor Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression

Paul Glue and Neil McNaughton
Journal of psychopharmacology (Oxford), 2698811241276505
12/09/2024
DOI: https://doi.org/10.1177/02698811241276505
Handle:
https://hdl.handle.net/10523/42361

Abstract

KRD ketamine scales
The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.

Metrics

12 Record Views

Details

Logo image